Clinical, neuropathologic and pharmacologic aspects of Huntington's disease: correlates with a new animal model.
D000818:Animals; D001921:Brain / Q000473:pathology; D003342:Corpus Striatum / Q000473:pathology / Q000503:physiopathology; D004195:Disease Models, Animal; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000503:physiopathology*; D007608:Kainic Acid / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011950:Receptors, Cholinergic / Q000502:physiology; D013378:Substantia Nigra / Q000503:physiopathology; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D011759:Pyrrolidines; D011950:Receptors, Cholinergic; D005680:gamma-Aminobutyric Acid; D007608:Kainic Acid